首页> 外文期刊>British Journal of Cancer >Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines
【24h】

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines

机译:柔红霉素和蒽吡唑酮在耐药细胞系中的敏感性和转运的比较

获取原文
           

摘要

Two P388 cell lines with acquired resistance to daunorubicin have been shown to exhibit cross-resistance to anthrapyrazolone (NSC 357885). The degree of cross-resistance observed in these cell lines (58 and 150 fold) is similar to those observed towards daunorubicin (34 and 142 fold). However the decreased drug accumulation observed for daunorubicin in the resistant cell lines (4-6 fold) is not observed for anthrapyrazolone. Similarly, verapamil can increase daunorubicin accumulation in resistant cells but has no effect on anthrapyrazolone accumulation. It is concluded that in contrast to daunorubicin, decreased anthrapyrazolone accumulation is not the resistance mechanism operative in daunorubicin resistant cell lines towards anthrapyrazolone.
机译:已显示两种获得的对柔红霉素具有抗性的P388细胞系对蒽吡唑酮(NSC 357885)表现出交叉抗性。在这些细胞系中观察到的交叉抗性程度(58和150倍)与对柔红霉素所观察到的交叉抗性(34和142倍)相似。然而,对于蒽吡酮,在耐药细胞系中观察到的柔红霉素药物积聚减少(4-6倍)。同样,维拉帕米可以增加柔红霉素在耐药细胞中的积累,但对蒽吡唑酮的积累没有影响。结论是,与柔红霉素相反,减少的蒽吡唑酮积累不是柔红霉素耐药细胞系对蒽吡唑酮的耐药机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号